AKT1 and leukemia: To investigate whether chidamide-induced anthracycline-resistant AML cells inhibition was associated with the inactivation of HDAC3 in an AKT-dependent manner, we overexpressed HDAC3 or AKT after chidamide-induced leukemia inhibition.